Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population

NCT06757049 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-01-03

No results posted yet for this study

Summary

The purpose of this study is to evaluate the early and mid-term safety and performance of the MITRIS RESILIA mitral valve in Asian patients in a real-world setting

Conditions

  • Mitral Valve Insufficiency

Sponsors & Collaborators

  • Edwards Lifesciences

    collaborator INDUSTRY
  • Asan Medical Center

    lead OTHER

Principal Investigators

  • HOJIN KIM, PI · cadiovascularthoracic surgery

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-20
Primary Completion
2031-03-31
Completion
2031-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06757049 on ClinicalTrials.gov